CNB-14450-56788
2 vaccinations
5 coded responses
8 check-ins
5 free-text entries
4 call cases
- Sex
- Female
- Age at first dose
- 66+
- ZIP prefix
- 902 / CA
- Registered
- 2021-03-01
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-23
Dose 1 — Pfizer-BioNTech
-
2021-02-13
Dose 2 — Pfizer-BioNTech
-
2021-03-01
Registered in v-safe
-
2021-03-01
Survey response — day 14, dose 2MedDRA: Dyspnoea exertional, Hypoaesthesia, Muscular weakness — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Bilateral numbness toes to saddle area, weakness in both legs; shortness of breath with mild exertion such as walking with walker support for 1 minute.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-06
Survey response — day 21, dose 2MedDRA: Condition aggravated, Hypoaesthesia, Mobility decreased, Muscular weakness, Myelitis transverse, Pre-existing disease — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Bilateral leg numbness and weakness, a regression of the transverse myelitis I had in acute stage October 2017. Residual deficit of impaired mobility had improved before my 2nd Pfizer vaccination on Feb. 13.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-06
Report sent to call center — day 21, dose 2Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
- 2021-03-13
- 2021-03-20
-
2021-03-27
Survey response — day 42, dose 2MedDRA: Hypoaesthesia, Muscular weakness — Feeling: Poor · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Numbness and weakness in both legs.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-27
Report sent to call center — day 42, dose 2Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
-
2021-05-15
Survey response — 3 months, dose 2MedDRA: Condition aggravated, Dyspnoea, Hypoaesthesia, Muscular weakness, Pre-existing disease, Tachycardia — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visitFree text: Increase of leg weaknesses and numbness causing shortness of breath and tachycardia. This noted relapse of transverse myelitis started after 2nd shot of Pfizer vaccine.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-05-15
Report sent to call center — 3 months, dose 2Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
- 2021-08-14
-
2022-02-13
Survey response — 12 months, dose 2MedDRA: Acupuncture, Pre-existing disease — Feeling: Poor · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Symptoms: Chronic pelvic pain · Healthcare visit (other): AcupunctureMedDRA releases: 2024-11 · check-in free text available
-
2022-02-13
Report sent to call center — 12 months, dose 2Be unable to do your normal daily activities · Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · 1 call case(s)
-
2022-02-15
Call successfulNot applicable (accidental reporting or does not believe symptoms are related to vaccine)
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-23 | Pfizer-BioNTech | |
| 2 | 2021-02-13 | Pfizer-BioNTech |
Call center
4 call center cases
4 successful
Free text
Release 4 — day 14, dose 2
Symptoms: Bilateral numbness toes to saddle area, weakness in both legs; shortness of breath with mild exertion such as walking with walker support for 1 minute.
Release 5 — day 21, dose 2
Symptoms: Bilateral leg numbness and weakness, a regression of the transverse myelitis I had in acute stage October 2017. Residual deficit of impaired mobility had improved before my 2nd Pfizer vaccination on Feb. 13.
Release 6 — day 42, dose 2
Symptoms: Numbness and weakness in both legs.
Release 8 — 3 months, dose 2
Symptoms: Increase of leg weaknesses and numbness causing shortness of breath and tachycardia. This noted relapse of transverse myelitis started after 2nd shot of Pfizer vaccine.
Release 11 — 12 months, dose 2
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Acupuncture | · | · | ✓ |
| SD | Condition aggravated | ✓ | ✓ | ✓ |
| SD | Dyspnoea | ✓ | ✓ | ✓ |
| SD | Dyspnoea exertional | ✓ | ✓ | ✓ |
| SD | Hypoaesthesia | ✓ | ✓ | ✓ |
| SD | Mobility decreased | ✓ | ✓ | ✓ |
| SD | Muscular weakness | ✓ | ✓ | ✓ |
| SD | Myelitis transverse | ✓ | ✓ | ✓ |
| SD | Pre-existing disease | ✓ | ✓ | ✓ |
| SD | Tachycardia | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release